Pacer Advisors Inc. Buys 427 Shares of Perrigo Company plc (NYSE:PRGO)

Pacer Advisors Inc. grew its stake in shares of Perrigo Company plc (NYSE:PRGO) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,337 shares of the company’s stock after buying an additional 427 shares during the quarter. Pacer Advisors Inc.’s holdings in Perrigo were worth $523,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Versant Capital Management Inc purchased a new stake in shares of Perrigo in the 4th quarter valued at $45,000. GAMMA Investing LLC increased its holdings in shares of Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock worth $49,000 after buying an additional 929 shares during the period. Central Pacific Bank Trust Division lifted its stake in shares of Perrigo by 33.3% in the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in Perrigo during the 3rd quarter valued at about $56,000. Finally, KBC Group NV grew its position in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock worth $118,000 after acquiring an additional 905 shares during the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Perrigo

In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company’s stock, valued at $152,912.43. This represents a 76.49 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.40% of the company’s stock.

Perrigo Price Performance

Shares of NYSE:PRGO opened at $25.08 on Wednesday. The business has a 50-day simple moving average of $25.88 and a two-hundred day simple moving average of $26.55. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The firm has a market cap of $3.42 billion, a price-to-earnings ratio of -21.44 and a beta of 0.54. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $33.46.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.81. The company had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.12 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.64 earnings per share. On average, analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. StockNews.com cut shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Saturday, January 11th. Finally, Argus downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $35.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.